Patrick J Beyer's Insider Trades & SAST Disclosures
Patrick J Beyer's most recent trade in Conmed Corp. was a trade of 86,355 Options To Purchase Common Stock done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Patrick J Beyer.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conmed Corp. | Patrick J. Beyer | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 86,355 | 86,355 | - | - | Options To Purchase Common Stock | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 965 | 49,943 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 965 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 26,493 | 26,493 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 48,978 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 0 | - | - | Restricted Stock Units | |
| Conmed Corp. | Patrick J. Beyer | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 68.30 per share. | 30 Apr 2024 | 3,000 | 10,807 (0%) | 0% | 68.3 | 204,900 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Apr 2024 | 20,060 | 20,060 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 44,677 | 44,677 | - | - | Options To Purchase Common Stock | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 965 | 965 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 965 | 18,578 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,400 | 30,400 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 17,613 (0%) | 0% | 0 | Class A Common Stock | |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 32,212 | 32,212 | - | - | Options To Purchase Common Stock | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 16,648 | 16,648 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 965 | 965 (0%) | 0% | 0 | Class A common stock | |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 965 | 1,930 | - | - | Restricted Stock Units | |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 55,000 | 55,000 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Sale of securities on an exchange or to another person at price $ 148.47 per share. | 03 Nov 2021 | 10,550 | 14,304 (0%) | 0% | 148.5 | 1,566,380 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Sale of securities on an exchange or to another person at price $ 149.20 per share. | 03 Nov 2021 | 6,497 | 7,807 (0%) | 0% | 149.2 | 969,346 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Sale of securities on an exchange or to another person at price $ 147.50 per share. | 03 Nov 2021 | 400 | 24,854 (0%) | 0% | 147.5 | 59,002 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 55,300 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.87 per share. | 29 Oct 2021 | 55,300 | 63,107 (0%) | 0% | 39.9 | 2,204,811 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 50,700 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.30 per share. | 29 Oct 2021 | 50,700 | 58,507 (0%) | 0% | 51.3 | 2,600,910 | Common Stock |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 34,906 | 34,906 | - | - | Stock Option (Right to Buy) | |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Payment of exercise price or tax liability using portion of securities received from the company at price $ 146.28 per share. | 29 Oct 2021 | 33,253 | 25,254 (0%) | 0% | 146.3 | 4,864,249 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.62 per share. | 29 Oct 2021 | 30,018 | 33,089 (0%) | 0% | 144.6 | 4,341,203 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Sale of securities on an exchange or to another person at price $ 145.31 per share. | 29 Oct 2021 | 16,904 | 13,396 (0%) | 0% | 145.3 | 2,456,270 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Sale of securities on an exchange or to another person at price $ 146.14 per share. | 29 Oct 2021 | 5,589 | 7,807 (0%) | 0% | 146.1 | 816,749 | Common Stock |
| Bioventus Inc - Ordinary S... | Patrick J. Beyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 2,895 | 2,895 | - | - | Restricted Stock Units | |
| Conmed Corp. | Patrick J. Beyer | President Intl & Global Ortho | Sale of securities on an exchange or to another person at price $ 144.50 per share. | 29 Oct 2021 | 2,789 | 30,300 (0%) | 0% | 144.5 | 403,002 | Common Stock |
| Conmed Corp. | Patrick J. Beyer | President - International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 46,750 | 46,750 | - | - | Options To Purchase Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges